NCT07388524 2026-05-13Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC TrialNational Cancer Institute (NCI)Phase 3 Not yet recruiting336 enrolled